How do you manage BRCA wild-type patients with an incidental STIC found at the time of an opportunistic salpingectomy?
Does your management change if the patient is a BRCA1/2 mutation carrier?
Answer from: at Academic Institution
I would consider having the pathology reviewed to be sure they agree with STIC, and also that they do not see invasive cancer. I would make sure the patient has had comprehensive genetic testing, as we have seen STICs even with non-BRCA genes. Regardless of genotype, but depending on the age of the ...